These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 15190602

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Current imaging methods in Graves' ophthalmopathy].
    Szúcs-Farkas Z, Galuska L, Nagy VE.
    Orv Hetil; 2004 Apr 25; 145(17):891-9. PubMed ID: 15170966
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Association Budd Chiari syndrome, antiphospholipid syndrome and Grave's disease].
    Mouelhi L, Chaieb M, Debbeche R, Salem M, Sfar I, Trabelsi S, Gorgi Y, Najjar T.
    Tunis Med; 2009 Feb 25; 87(2):164-6. PubMed ID: 19522454
    [Abstract] [Full Text] [Related]

  • 27. "Balanced" orbital decompression for severe Graves' orbitopathy: technique with treatment algorithm.
    Kacker A, Kazim M, Murphy M, Trokel S, Close LG.
    Otolaryngol Head Neck Surg; 2003 Feb 25; 128(2):228-35. PubMed ID: 12601319
    [Abstract] [Full Text] [Related]

  • 28. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P, Berman DC, Andersen S, Bülow Pedersen I.
    Thyroid; 2011 Sep 25; 21(9):951-6. PubMed ID: 21834677
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy].
    Pauleit D, Schüller H, Textor J, Leutner C, Keller E, Sommer T, Träber F, Block W, Boldt I, Schild H.
    Rofo; 1997 Dec 25; 167(6):557-64. PubMed ID: 9465949
    [Abstract] [Full Text] [Related]

  • 31. General hyperpigmentation induced by Grave's disease: A case report.
    Song X, Shen Y, Zhou Y, Lou Q, Han L, Ho JK, Ren Y.
    Medicine (Baltimore); 2018 Dec 25; 97(49):e13279. PubMed ID: 30544387
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy.
    Bartalena L.
    J Clin Endocrinol Metab; 2011 Mar 25; 96(3):592-9. PubMed ID: 21190983
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Thyroid eye disease: review and case reports.
    McGarvey EJ.
    J Am Optom Assoc; 1990 Sep 25; 61(9):689-700. PubMed ID: 2212462
    [Abstract] [Full Text] [Related]

  • 38. [Thyroid gland function and endocrine orbitopathy].
    Haas HG.
    Klin Monbl Augenheilkd; 1993 May 25; 202(5):453-4. PubMed ID: 8377414
    [Abstract] [Full Text] [Related]

  • 39. [Thyroid cancer in patients with Grave's Disease].
    Mssrouri R, Benamr S, Essadel A, Mdaghri J, Mohammadine el H, Lahlou MK, Taghy A, Belmahi A, Chad B.
    J Chir (Paris); 2008 May 25; 145(3):244-6. PubMed ID: 18772732
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.